Cost Plus Drugs co-founder berates benefit advisers for not emphasizing cash carveouts as he seeks to better educate CEOs on ...

What’s more elusive than a campaign promise in an election year? A $2,000 “tariff dividend” check that’s being touted as ...

From asbestos to zinc oxide, class action litigation has touched nearly every corner of American industry. So perhaps it was inevitable this day would come: A class action about class actions.

A federal judge in Texas on Monday granted final approval to a settlement resolving claims that Charles Schwab's merger with TD Ameritrade violated antitrust law and awarded the plaintiffs’ lawyers $8 ...